Ferring Pharmaceuticals (Private)
Quick facts
| Ticker | Private (Private) |
|---|
Marketed products
- Choriongonadotropin · Other
- Choriogonadotropin · Metabolic
- Acthrel · Nephrology
- Crinone · Other
- Firmagon · Oncology
Firmagon works by blocking the action of gonadotropin-releasing hormone on the pituitary gland, which reduces testosterone production. - Endometrin · Women's Health
- Glycerine · Metabolic
- Menotrophin · Other
- Menopur · Other
MENOPUR promotes ovarian follicular growth and maturation, requiring hCG for ovulation. - MINIRIN Oral Lyophilisate
- PICOPREP · Other
- Primary nocturnal enuresis
- REBYOTA™ · Other
Phase 3 pipeline
Phase 2 pipeline
- Norprolac · Other
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Ferring Pharmaceuticals
What is the ticker symbol for Ferring Pharmaceuticals?
Ferring Pharmaceuticals trades as Private on the Private.
What are Ferring Pharmaceuticals's marketed drugs?
Top marketed products include Choriongonadotropin, Choriogonadotropin, Acthrel, Crinone, Firmagon, Endometrin.
What is Ferring Pharmaceuticals's pipeline?
Ferring Pharmaceuticals has 2 drugs in Phase 3, 1 in Phase 2, 0 in Phase 1. Late-stage candidates include FE 999326, Recombinant Human Follitropin Alfa.
Related
- Choriongonadotropin · Other
- Choriogonadotropin · Metabolic
- Acthrel · Nephrology
- Crinone · Other
- Firmagon · Oncology
- Sector hub: All tracked pharma companies
- Ticker: Private · Private